References
- Ahlmen J, Gustafsson A, Storm B. Morbidity in azotemia and mortality in uraemia. Acta Med Scand 1972; 192: 113–118.
- Ahonen A, Penttilä A. Mortality and autopsy rate from urogenital diseases in Finland 1955–1973. Scand J Urol Nephrol 1980; 14: 91–99.
- Dubach UC, Rosner B, Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin. New Engl J Med 1983; 308: 357–362.
- Hamtoft H, Mosbech J. Mortality trends in renal disease. Lancet 1968; 1: 751–752.
- Hood B, Falkheden T, Carlsson M. Trends and present pattern of mortality in chronic uraemia. Acta Med Scand 1967; 181: 561–569.
- Kasanen A, Forsström J, Salmi HA. On the commonness, causes and detrimental effects of the use of analgesics by factory workers and hospital patients. Acta Med Scand 1962; 172: 15–19.
- Kasanen A. The effect of the restriction of the sale of phenacetin on the incidence of papillary necrosis established at autopsy. Ann Clin Res 1973; 5 : 369–374.
- Kessner DM, Florey CV. Mortality trends for acute and chronic nephritis and infections of the kidney. Lancet 1967; 2: 979–982.
- Mabeck CE, Wichmann B. Nyresygdomme som døds-årsag i Danmark 1941–1975. Ugeskr Laeg 1978; 140: 2933–2935.
- Pasternack A, Kasanen A, Sourander L, Kaarsalo E. Den kroniska uremins epidemiologi och bedömning av behandlingsbehovet. Finska Läkaresällskapets Hand-lingar 1975; 135: 151–156.
- Sillanpää M, Kasanen A, Elonen A. Changes of panorama in renal diseases mortality in Finland after phenacetin restriction. Acta Med Scand 1982; 212: 313–317.
- Waters WE. Trends in mortality from nephritis and infections of the kidney in England and Wales. Lancet 1968; 1: 241–243.